Serum Anti-mullerian Hormone, Serum Inhibin B and Antral Follicle Count for Prediction of ovarian Reserve in Patients Undergoing Intracytoplasmic Sperm Injection

Abstract

his study is an observational prospective study, included 100 women aged between 25 and 35 years, was enrolled for intracytoplasmic sperm injection (ICSI) with the inclusion and exclusion criteria: Inclusion criteria: • First stimulation cycle for intracytoplasmic sperm injection (ICSI). • A long protocol for the use of a gonadotrophin releasing hormone agonist (GnRHa). • The presence of both ovaries. • Unexplained infertility. • Infertility due to fallopian tube factor. • No evidence of endocrine disorders including diabetes mellitus(normal TSH, prolactin). • A Body Mass Index ranging from 25 to 35 Kg/m2. • Not on hormone therapy as human chorionic gonadotropin (HCG),human menopausal gonadotropin (HMG) before ICSI cycle. • No history of ovarian surgery. • Serological markers for hepatitis B, C, and HIV are negative.